Logotype for Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals (539730) investor relations material

Fredun Pharmaceuticals Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Fredun Pharmaceuticals Limited
Q1 25/26 earnings summary1 Aug, 2025

Executive summary

  • Achieved 52% year-over-year revenue growth in Q1 FY26, reaching INR 119.86 crores, with strong expansion in higher-margin pet healthcare verticals.

  • Net profit rose 64% to INR 6.77 crores, and EPS increased over 63% to 14.33 year-over-year.

  • Order book exceeds INR 200 crores, providing strong visibility for upcoming quarters.

  • Board approved unaudited financial results for the quarter ended 30 June 2025 and received a limited review report from statutory auditors with an unmodified conclusion.

  • Strategic focus on branded generics, pet care, nutraceuticals, and mobility aids, with a shift from OEM to own brands.

Financial highlights

  • EBITDA grew 62% year-over-year to INR 16.99 crores, with margin expansion to 14.18%.

  • Consolidated revenue for the quarter ended 30 June 2025 was ₹11,985.50 lakhs, compared to ₹7,881.08 lakhs in the same quarter last year.

  • Net profit for the quarter was ₹676.58 lakhs, up from ₹412.99 lakhs year-over-year.

  • Basic and diluted EPS for the quarter stood at ₹14.33, compared to ₹8.79 in the same quarter last year.

  • Inventory stands at over INR 200 crores; receivables as of July 31 are under INR 100 crores, with receivable days at 120–130.

Outlook and guidance

  • Targeting to double revenue and PAT in 3–4 years, aiming for INR 800+ crore top line and INR 90+ crore PAT, with PAT margin of 10–11%.

  • Vintage business expected to grow 15–20% year-over-year, supported by 1,290 product registrations in the pipeline.

  • New Age business (pet care, nutrition, mobility, wellness) expected to grow at 35–40% CAGR.

  • By FY29, entire revenue to be driven by vintage generics; by FY32, over 51% from New Age business.

  • Financial results were prepared in compliance with Ind AS and reviewed by statutory auditors, indicating continued adherence to regulatory and accounting standards.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Fredun Pharmaceuticals earnings date

Logotype for Fredun Pharmaceuticals Limited
Q2 25/2624 Oct, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Fredun Pharmaceuticals earnings date

Logotype for Fredun Pharmaceuticals Limited
Q2 25/2624 Oct, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Fredun Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing and export of a wide range of medicinal products. The company produces formulations including tablets, capsules, powders, and liquid orals across various therapeutic categories. It operates as a contract manufacturer for global pharmaceutical brands and also markets its own branded generics. Fredun Pharmaceuticals Limited serves both domestic and international markets, complying with regulatory standards in multiple regions. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage